CLINICAL_TRIALS
trial_result
· 2015-12-10
Clinical Trial Update: A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003) [Phase 1]
Summary
Phase 1 clinical trial evaluating single doses of MK-1064 and MK-6096 on polysomnography; completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Polysomnography | Phase 1 | Status: COMPLETED | Results posted: 2015-12-10